Tavotek Biotherapeutics
Industry
- Biotechnology
- Pharmaceuticals
- Specialty Pharmaceuticals
See more in Biomedtracker
Latest on Tavotek Biotherapeutics
Scrip
• By Dexter Jie Yan
Since LianBio 's initial public listing on Nasdaq in the US, Chinese biotechs continued to attract substantial funding in the last two weeks of November, with mRNA technologies bagging the most atten
Scrip
• By Joseph Haas, Ian Haydock, and Vibha Ravi
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Visus Licenses Drugs From Cella, Delive
Scrip
• By Mandy Jackson
Venture capital investment in biopharmaceuticals companies reached a new record in 2020 and in 2021 the pace of new financings remains robust with many large VC rounds. Venture capital firms also cont